Item 7.01. Regulation FD Disclosure.





Preferred Stock Dividends

On September 23, 2022, Healthcare Trust, Inc. (the "Company") issued a press release announcing the declaration of a dividend of $0.4609375 per share payable on October 17, 2022 to holders of record of shares of the Company's 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock at the close of business on October 7, 2022.

In addition, the Company announced the declaration of a dividend of $0.4453125 per share payable on October 17, 2022 to holders of record of shares of the Company's 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock at the close of business on October 7, 2022.

A copy of the press release is attached as Exhibit 99.1, and is hereby incorporated by reference into this Item 7.01. This press release shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in Item 7.01, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.

The statements in this Current Report on Form 8-K that are not historical facts may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results or events to be materially different. The words "may," "will," "seeks," "anticipates," "believes," "expects," "estimates," "projects," "plans," "intends," "should" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to a number of risks, uncertainties and other factors, many of which are outside of the Company's control, which could cause actual results to differ materially from the results contemplated by the forward-looking statements. These risks and uncertainties include (a) the impact of inflation on the Company and its costs and expenses, (b) the potential adverse effects of (i) the ongoing global COVID-19 pandemic, including actions taken to contain or treat COVID-19, and (ii) the geopolitical instability due to the ongoing military conflict between Russia and Ukraine, including related sanctions and other penalties imposed by the U.S. and European Union, and other countries, as well as other public and private actors and companies, and the related impact on the Company, the Company's tenants, the Company's operators and the global economy and financial markets, and (c) that any potential future acquisition is subject to market conditions and capital availability and may not be identified or completed on favorable terms, or at all, as well as those risks and uncertainties set forth in the Risk Factors section of the Company's Annual Report on Form 10-K for the year ended December 31, 2021 filed on March 18, 2022, and all other filings with the Securities and Exchange Commission after that date, as such risks, uncertainties and other important factors may be updated from time to time in the Company's subsequent reports. Further, forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise any forward-looking statement to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results, unless required to do so by law.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.   Description
  99.1          Press Release, dated September 23, 2022.
104           Cover Page Interactive Data File - the cover page XBRL tags are embedded
              within the Inline XBRL document

© Edgar Online, source Glimpses